Navigation Links
Curoverse Raises $1.5 Million to Build Open Source Platform for Genomic and Biomedical Big Data

Boston, MA (PRWEB) December 18, 2013

Curoverse announced today the company has raised $1.5 million to accelerate development of the Arvados free and open source software platform for genomic and biomedical big data and to deliver new products based on the platform.

Arvados is a computational storage platform designed for the biomedical industry. The first deployment of Arvados runs a private cloud with 300 TB of storage and 500 cores that is used for genomic analysis at the Harvard Personal Genome Project and for research work at Harvard Medical School.

"Responding to explosive growth in genomic and biomedical data, research and clinical labs are turning to technologies that have made web-scale computing possible, but existing solutions are failing to address the complex needs of the biomedical industry," said Adam Berrey, chief executive officer of Curoverse. "We are enabling a new generation of bioinformatics computing systems with a complete stack of commercially-supported, community-driven, open-source technologies that apply elastic computing and big-data strategies to the unique requirements of genomic research and precision medicine."

Arvados was originally developed by a team of scientists and software engineers led by Alexander Wait Zaranek, Ph.D. in the Church lab at Harvard Medical School. The platform includes a content addressable distributed storage system and a computational management system designed to make complex analyses easily reproducible.

"Translating the innovations in genomic sequencing into meaningful medical care will require transparent informatics resources that combine open source software and public domain datasets," said Dr. George Church, professor of genetics at Harvard Medical School. "The Arvados software and the data collected through Personal Genome Projects can be a foundation for the development and delivery of precision medicine in cancer, neo-natal care, inherited diseases, pharmacogenomics, and a variety of other applications."

The series seed financing round included investments from Hatteras Venture Partners, Point Judith Ventures, Common Angels, MassVentures, and Boston Global Ventures.

"For the last several years we have closely followed the market for bioinformatics platforms that address new challenges created by next-generation sequencing and biomedical big data," said Clay Thorp, general partner at Hatteras Venture Partners. "Curoverse has a clear strategy to use open source technology with a unique go-to-market model that is well-aligned with the needs of research and clinical customers."

Curoverse is available today through a private beta program. The company plans to release their first commercial products in 2014. The Arvados software is available at

About Curoverse

Curoverse is a venture-backed startup developing computational storage infrastructure for a new era of precision medicine driven by genomic and biomedical big data. Based in Boston, Curoverse is a major contributor to the Arvados free and open source software project. Curoverse was formerly known as Clinical Future, Inc. More information is available about the company at

Press Contact
Jonathan Sheffi, Curoverse
(617) 448-9298

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. The Holistic Sanctuary Raises Alarm About Teenage Drug Addiction
2. Immune Design Raises Up to $49 Million Series C Financing
3. Acacia Pharma Raises £15 Million ($23.5 Million) to Advance Clinical Development of Lead Products for Supportive Care
4. Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives
5. Advanced Animal Diagnostics Raises $6 Million for On-farm Diagnostics
6. OriGene Technologies Raises $21.3 Million in Series C Funding
7. Z Trim Holdings Announces Conclusion of Successful Warrant Exercise Program: Raises $2.195 Million
8. Strand Raises Series B From Burrill & Company
9. Ian Somerhalder Raises Big Money for the Environment; Optimal Chemical Comments His Effort Proves He's a True Green Celebrity
10. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
11. OxThera Raises Capital for Further Clinical Development of Oxabact(R)
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... The Academy of Model ... Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person View ... years. Many AMA members have embraced this type of racing and several new model ...
(Date:11/24/2015)... Israel , Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) ... on December 29, 2015 at 11:00 a.m. Israel ... Electra Tower, 98 Yigal Allon Street, 36 th Floor, ... of Eric Paneth and Izhak Tamir to the ... Rami Skaliter as external directors; , approval of an amendment to ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... the environment are paramount. Insertion points for in-line sensors can represent a weak ... the InTrac 781/784 series of retractable sensor housings , which are designed ...
(Date:11/24/2015)... Nov. 24, 2015 /CNW Telbec/ - ProMetic Life Sciences Inc. ... that Mr. Pierre Laurin , President and Chief Executive ... the upcoming Piper Jaffray 27 th Annual Healthcare Conference ... December 1-2, 2015. st , at 8.50am ... meetings throughout the day. The presentation will be available live ...
Breaking Biology Technology:
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... today announced broader entry into the automotive market with ... match the pace of consumer electronics human interface innovation. ... are ideal for the automotive industry and will be ... Europe , Japan ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
Breaking Biology News(10 mins):